BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17722791)

  • 1. [Role of mitochondrial dysfunction in non-alcoholic steatohepatitis].
    Elloumi H; Arfaoui D; Nabli N; Ajmi S
    Tunis Med; 2003 Oct; 81(10):763-7. PubMed ID: 17722791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-alcoholic steatohepatitis and metabolic syndrome.
    Machado M; Cortez-Pinto H
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathogenic molecular mechanisms in non-alcoholic steatohepatitis].
    Alvarez-Martínez HE; Montaño-Estrada LF; Hernández-Cruz P; Pérez-Campos E
    Rev Gastroenterol Mex; 2004; 69(3):176-83. PubMed ID: 15759791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease.
    Gulsen M; Yesilova Z; Bagci S; Uygun A; Ozcan A; Ercin CN; Erdil A; Sanisoglu SY; Cakir E; Ates Y; Erbil MK; Karaeren N; Dagalp K
    J Gastroenterol Hepatol; 2005 Sep; 20(9):1448-55. PubMed ID: 16105135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of non-alcoholic steatohepatitis.
    McClain CJ; Mokshagundam SP; Barve SS; Song Z; Hill DB; Chen T; Deaciuc I
    Alcohol; 2004 Aug; 34(1):67-79. PubMed ID: 15670668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of non-alcoholic steatohepatitis: human data.
    Edmison J; McCullough AJ
    Clin Liver Dis; 2007 Feb; 11(1):75-104, ix. PubMed ID: 17544973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review article: the pathogenesis of fibrosis in non-alcoholic steatohepatitis.
    Marra F; Aleffi S; Bertolani C; Petrai I; Vizzutti F
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():44-7. PubMed ID: 16225472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance in patients with steatohepatitis.
    Saglam K; Kiliç R; Yilmaz MI; Gulec M; Baykal Y; Kutlu M
    Hepatogastroenterology; 2003; 50(50):456-9. PubMed ID: 12749246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
    Petta S; Muratore C; Craxì A
    Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
    Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Obesity and non-alcoholic steatohepatitis].
    Méndez-Sánchez N; Chávez-Tapia NC; Uribe M
    Gac Med Mex; 2004; 140 Suppl 2():S67-72. PubMed ID: 15641474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty liver and insulin resistance in obese Zucker rats: no role for mitochondrial dysfunction.
    Flamment M; Arvier M; Gallois Y; Simard G; Malthièry Y; Ritz P; Ducluzeau PH
    Biochimie; 2008 Sep; 90(9):1407-13. PubMed ID: 18534199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis.
    Cusi K
    Clin Liver Dis; 2009 Nov; 13(4):545-63. PubMed ID: 19818304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model.
    Serviddio G; Bellanti F; Tamborra R; Rollo T; Romano AD; Giudetti AM; Capitanio N; Petrella A; Vendemiale G; Altomare E
    Eur J Clin Invest; 2008 Apr; 38(4):245-52. PubMed ID: 18339004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance.
    Raffaella C; Francesca B; Italia F; Marina P; Giovanna L; Susanna I
    Obesity (Silver Spring); 2008 May; 16(5):958-64. PubMed ID: 18277391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The therapeutic effect of metadoxine on alcoholic and non-alcoholic steatohepatitis].
    Váli L; Blázovics A; Fehér J
    Orv Hetil; 2005 Nov; 146(47):2409-14. PubMed ID: 16398154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the slippery slope from steatosis to steatohepatitis paved with triglyceride or cholesterol?
    Ginsberg HN
    Cell Metab; 2006 Sep; 4(3):179-81. PubMed ID: 16950134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial involvement in non-alcoholic steatohepatitis.
    Serviddio G; Sastre J; Bellanti F; Viña J; Vendemiale G; Altomare E
    Mol Aspects Med; 2008; 29(1-2):22-35. PubMed ID: 18061659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet.
    Romestaing C; Piquet MA; Letexier D; Rey B; Mourier A; Servais S; Belouze M; Rouleau V; Dautresme M; Ollivier I; Favier R; Rigoulet M; Duchamp C; Sibille B
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E110-9. PubMed ID: 17986629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.